Galaxy Ring Bundling Threatens Ultrahuman
Diving deeper into
Ultrahuman
The risk for Ultrahuman is that Samsung makes ring-based health tracking a bundled component of the Android premium experience
Analyzed 8 sources
Reviewing context
Samsung is dangerous to Ultrahuman not because it must win on ring quality, but because it can turn the ring into a cheap add on inside a much bigger phone and watch bundle. Ultrahuman still depends on selling a standalone device, while Samsung can use Galaxy Ring to make Galaxy phones, watches, Samsung Health, and Galaxy AI feel more complete, even if the ring itself is only one part of the value.
-
Samsung sells Galaxy Ring from $299.99 in the US, markets it through Samsung Health and Galaxy AI, and explicitly promotes it alongside Galaxy Watch as an ultimate tracking team. That means Samsung can treat ring margin as flexible if the bundle helps retain premium Android users.
-
Ultrahuman is much more exposed to ring demand. Smart rings are still its main revenue source, it has sold about 800,000 rings cumulatively, and only about 12% of users pay for PowerPlugs. If Samsung normalizes the ring as a bundled premium feature, standalone ring brands have less room to charge for the hardware itself.
-
The closest precedent is Oura, which used software, retail expansion, and ecosystem depth to grow to about $1B of revenue in 2025 and more than five million members. That shows the category can scale, but it also shows how much distribution and product surface area matter once rings stop being a niche gadget.
The category is heading toward platform competition, not sensor competition. Ultrahuman's best path is to make the ring the entry point into a broader health stack with glucose, labs, and paid modules before Samsung and other large ecosystems teach Android users to expect ring tracking as a built in part of the premium device experience.
Conversation has been deleted
Start new chat